TritonPoint Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
10,428
-105
-1% -$27.6K 0.29% 81
2026
Q1
$2.81M Sell
10,533
-411
-4% -$111K 0.3% 78
2025
Q4
$2.75M Sell
10,944
-3
-0% -$797 0.28% 84
2025
Q3
$3.14M Sell
10,947
-233
-2% -$62.4K 0.27% 91
2025
Q2
$2.93M Buy
11,180
+291
+3% +$70.9K 0.27% 92
2025
Q1
$2.53M Buy
10,889
+147
+1% +$35.7K 0.24% 99
2024
Q4
$2.46M Sell
10,742
-25
-0.2% -$5.74K 0.22% 103
2024
Q3
$2.39M Sell
10,767
-835
-7% -$184K 0.22% 105
2024
Q2
$2.36M Sell
11,602
-1
-0% -$203 0.23% 103
2024
Q1
$2.63M Buy
11,603
+11
+0.1% +$2.42K 0.28% 87
2023
Q4
$2.63M Buy
+11,592
New +$2.44M 0.26% 92

Other funds holding LH

TritonPoint Wealth's LH Position: Q2 2026 in Review

TritonPoint Wealth reduced its Labcorp (LH) stake by 1% in Q2 2026, selling an estimated $27.6K and leaving 10,428 shares worth $2.92M. The position accounts for 0.29% of the portfolio, ranked #81.

TritonPoint Wealth first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.14M in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • TritonPoint Wealth held 10,428 shares of Labcorp worth $2.92M as of Q2 2026.
  • TritonPoint Wealth sold 105 Labcorp shares in Q2 2026, an estimated $27.6K.
  • Labcorp made up 0.29% of TritonPoint Wealth's portfolio in Q2 2026, its #81 holding.
  • TritonPoint Wealth first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • TritonPoint Wealth's Labcorp position peaked at $3.14M in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on TritonPoint Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.